A multicenter, retrospective analysis of elderly patients with acute myeloid leukemia who were treated with decitabine

Decitabine is widely accepted as the treatment options for elderly acute myeloid leukemia (AML) patients. However, the efficacy has yet been assessed in Asian population. We retrospectively analyzed the outcomes of 80 Korean elderly AML patients who were treated with decitabine. The median age was 7...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Jun Ho, Park, Silvia, Kim, Jung Han, Won, Young-Woong, Lim, Do Hyoung, Han, Boram, Uhm, Jieun, Kim, Hae Su, Jung, Chul Won, Jang, Jun Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814236/
https://www.ncbi.nlm.nih.gov/pubmed/29464096
http://dx.doi.org/10.18632/oncotarget.23823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814236/
https://www.ncbi.nlm.nih.gov/pubmed/29464096
http://dx.doi.org/10.18632/oncotarget.23823

Ejemplares similares